Moving Beyond "Better" to Getting Patients "Well": Tools to Measure How "Well" Your Patient is Doing With TreatmentPremiere Date: Friday, May 3, 2019
This activity offers CE credit for:%>
- Physicians (CME)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, December 31, 2020
Note: Credit Is No Longer Available
|Gregory W. Mattingly, MD
Associate Clinical Professor
Washington University School of Medicine
St. Louis, MO
President, Midwest Research Group
Midwest Research Group
St. Charles, MO
Board of Directors, APSARD - American Professional Society for ADHD and Related Disorders
Primary care has become the point-of-care where most people seek treatment for depression, and effort to improve depression outcomes in primary care have focused on improved screening and implementation of collaborative and measurement-based care. However, a recent study showed that only 35.7% of patients diagnosed with depression had treatment initiated, despite the demonstrated value of consistently monitoring and measuring symptomatology and daily functioning of patients with depression. Measurement-based care strategies are essential to provide the best chance for successful treatment and sustained remission.
In part 2 of this free CME Outfitters Snack series, expert faculty present an engaging, focused video discussion using the ArchViewer platform to discuss a measured approach to screening and treating depression including the feasibility, necessity, and effectiveness of these practices to enhance patient care.
At the end of this CE activity, participants should be able to:
- Utilize measurement-based care tactics to ensure your patients are not just better, but are getting well.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Explain the use of measurement-based care tactics to evaluate treatment response with a goal of sustained remission.
Supported by an educational grant from Otsuka America Pharmaceutical, Inc and Lundbeck.
Primary care physicians, physician assistants, nurse practitioners, nurses, and pharmacists who manage patients with depression.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Mattingly reports that he is a consultant for Alkermes; Allergan; FORUM Pharmaceuticals Inc.; Lundbeck; Merck & Co., Inc.; Otsuka America Pharmaceutical, Inc.; Purdue Pharma L.P.; Rhodes Pharmaceuticals L.P.; Shire; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and Vanda Pharmaceuticals. He receives research grants from Akili Interactive Labs, Inc.; Alcobra Ltd; Alkermes; Allergan; Boehringer Ingelheim; FORUM Pharmaceuticals Inc.; Janssen Pharmaceuticals, Inc.; Medgenics; NLS-1 Pharma AG; Reckitt Benckiser Group plc; Shire; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; and Takeda Pharmaceuticals U.S.A., Inc. He is on the speakers bureaus for Allergan; Alkermes; Lundbeck; Merck & Co., Inc.; NEOS Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; Shire; Sunovio Pharmaceuticals Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and Vanda Pharmaceuticals.
Jeffrey Helfand, DO, MS (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty has been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).